_(7184104335).avif)
Why Failure-to-Market Claims Are Preempted Under Federal Law
This short white paper addresses preemption arguments relevant to “failure to market” claims, which cover those cases in which plaintiffs allege that drug companies may be held liable for failing to bring to market, as quickly as possible, drugs that present (allegedly) fewer side effects than other, FDA-approved drugs already on the market.
A California appellate court invented out of whole cloth a new and troubling theory of tort liability. Specifically, the court held that drug companies have a duty to develop and bring to market drugs that are supposedly safer and more effective than another, FDA-approved drug the company sells already. The claim rested on factual premises contradicted by all publicly available information, the acceptance of which could seriously disrupt the FDA approval process. This disruption gives rise to an issue the parties did not raise on appeal and that the appeals court never addressed, notwithstanding the complex, comprehensive statutes governing drug approval: these state tort law claims are preempted under theories of both field and conflict (including obstacle) preemption. This White Paper explains why it is imperative for the federal government and private parties to advance these preemption arguments, and why the courts should accept them.
Read the Issue Brief
This white paper was originally published by the Pacific Research Institute's Center for Medical Economics and Innovation.
Economic Dynamism

Do Dynamic Societies Leave Workers Behind Economically?
We need a more dynamic economy that can help workers by allowing them to move where they can best use their skills.
.jpg)
Do Dynamic Societies Leave Workers Behind Culturally?
Technological change is undoubtedly raising profound metaphysical questions, and thinking clearly about them may be more consequential than ever.

The War on Disruption
The only way we can challenge stagnation is by attacking the underlying narratives. What today’s societies need is a celebration of messiness.
Unlocking Public Value: A Proposal for AI Opportunity Zones
Governments often regulate AI’s risks without measuring its rewards—AI Opportunity Zones would flip the script by granting public institutions open access to advanced systems in exchange for transparent, real-world testing that proves their value on society’s toughest challenges.

Downtowns are dying, but we know how to save them
Even those who yearn to visit or live in a walkable, dense neighborhood are not going to flock to a place surrounded by a grim urban dystopia.

AI Needs Consumer Choice, Not Bureaucratic Control
The regulatory approach treats consumer AI as a problem to be solved rather than as another service best left to a competitive, dynamic market to provide consumers with autonomy and choice.

The Start-Up Paradox: The Coming Red Shift in Innovation
Despite London's success, the future of innovation is securely in American hands for the foreseeable future.
.avif)



.jpeg)




.jpg)




